Displaying items by tag: ILNA Category: Oncologic Emergencies

2:15 – 3:15 pm Saturday, September 15

Transfusions in Pediatric Hematology/Oncology Patients: As Easy As ABO (231)

1CNE  Transfusion of blood products is an essential part of caring for children with benign hematologic disorders, malignant diseases, and those undergoing hematopoietic stem cell transplants. One challenge in pediatric patients is the broad age range for patients that span from neonates to young adults. Recent studies have shown that there is a wide variability in practice among pediatric programs in the indications for transfusions, CMV prevention, and management of patients who become refractory to transfusions.

12:10 – 12:30 pm Saturday, September 15

Paper Presentations: Clinical Care Issues — Improving Patient Identification Practices in a Central American Pediatric Cancer Hospital (228-3)

1CNE  Participants will identify the nurse’s unique role in promoting a culture of safety and continuous quality improvement through the implementation of a correct patient identification quality improvement project in a Central American pediatric cancer hospital.

Disclaimer: [1 CH] will be awarded for attending all three paper presentations presented during this timeslot. Partial credit is not available.

11:50 am – 12:10 pm Saturday, September 15

Paper Presentations: Clinical Care Issues — Implementation of an Inpatient Oncology Resource Nurse to Standardize and Improve Chemotherapy Admission Workflow (228-2)

1CNE  Basis of inquiry: Our 32-bed inpatient oncology unit identified delays in initiating chemotherapy for scheduled patients. With an increased census and tightened staffing ratios, the chemotherapy admission process became increasingly inefficient. These delays resulted in frustration for both patients and healthcare providers.

Purpose/Objectives: The aim of this project was to devise and evaluate a more efficient and consistent admission process through the use of a resource nurse. We sought to develop a workflow to deliver “on time” chemotherapy, defined as prior to shift change at 7 pm. This would reduce delays and increase satisfaction of patients, families, and providers.

11:30 am – 11:50 am Saturday, September 15

Paper Presentations: Clinical Care Issues — Use of a Clinical Care Pathway for the Evaluation and Treatment of Children with Acute Chest Syndrome (228-1)

1CNE Acute chest syndrome is the leading cause of death and hospitalization among patients with sickle cell disease. Nurses have an important role in providing prompt evaluation and treatment of the child with acute chest syndrome. Evidence-based clinical care pathways are recommended to improve quality of care and to help reduce the length of hospitalization. This presentation will review the development of a standardized clinical care pathway which includes recommendations for management, diagnostic work up, and treatment strategies.

11:00 am – Noon Friday, September 14

High Risk Therapy Made Easy: Supporting High Risk Patients Through Complex Therapy (215)

1CNE  High risk (HR) pediatric oncology patients continue to undergo new and emerging treatment protocols, which have multiple complications that patients may encounter. Accurate assessment and early interventions is key to supporting patients through therapy. This session will focus on supportive cares for relapse leukemia and HR neuroblastoma patients; with special focus on the immunotherapy drugs blinatumomab and dinutuximab as well as infection prophylaxis. Most frequent serious adverse events noted in patients treated with blinatumomab are disorders of the nervous system and systemic cytokine release syndrome (CRS). Events are usually reversible and able to be managed with attentive supportive care. Most frequent side effects noted in patient treated with dinutuximab are pain, hypersensitivity reactions, CRS, capillary leak, fevers, and hypotension. We will use case studies of HR patients.

Subscribe to this RSS feed